Breast Cancer Update for Oncology Nurses
A Continuing Education (CE) Audio Series Activity |
STATEMENT OF NEED / TARGET AUDIENCE
Medical oncology, particularly breast cancer, is one of the most rapidly advancing and developing fields of
medicine. The constant emergence of new systemic agents, new indications for existing systemic agents, novel
therapies, clinical trials and research findings demand that oncology nurses remain dedicated to continuing
education in order to offer their patients the best care possible. This program provides registered nurses access
to the most up-to-date research developments in breast cancer and the opinions of oncology nurses and research
leaders with experience and expertise in the field. This information can be effectively translated into everyday
patient management decisions.
PURPOSE STATEMENT
To present the most current research developments in breast cancer and to provide the perspectives of medical
oncologists, oncology nurses and patients on the diagnosis and treatment of breast cancer.
EDUCATIONAL OBJECTIVES FOR THIS ISSUE OF BREAST CANCER UPDATE FOR ONCOLOGY NURSES
Upon completion of this activity, participants should be able to:
- Discuss the basis for selection and sequence of hormonal therapies in the metastatic setting.
- Discuss the clinical implications of the adjuvant endocrine therapy trials for postmenopausal women
with ER-positive primary disease.
- Discuss the rationale for selection of various chemotherapeutic agents in the adjuvant and
metastatic settings.
- Discuss the risks and benefits of various chemotherapeutic agents in the adjuvant and metastatic settings.
ACCREDITATION STATEMENTS
This educational activity for 3.0 contact hours is provided by Postgraduate Institute for Medicine. Postgraduate
Institute for Medicine is an approved provider of continuing education by the Colorado Nurses Association, an
accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
California Board of Registered Nursing
Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number
13485, for 3.0 contact hours.
A statement of credit will be issued only upon receipt of a completed post-test and activity evaluation form and will
be mailed within three weeks.
HOW TO USE THIS MONOGRAPH
This CE activity contains both audio and print components. This monograph contains edited comments, clinical trial
schemas, graphics and references that supplement the audio program.
www.BreastCancerUpdate.com/Nurses includes an easy-to-use, interactive version of this monograph with
links to relevant full-text articles, abstracts, trial information and other web resources indicated here in blue
underlined text. There are no fees for participating and receiving CE credit for this activity. To receive credit
during the period of October 2005 through October 2006, participants should read the learning objectives and
faculty disclosures, listen to the CDs or tapes, review the monograph and complete the post-test and evaluation
form located in the back of this monograph or on the www.BreastCancerUpdate.com/Nurses website and
mail or fax the evaluation form to Postgraduate Institute for Medicine.
|